三、结论

更新于 2026年11月19日 版权声明
三、结论

综上所述,抑郁症和老年心血管疾病密切相关,但两者共病的潜在机制仍不清楚。研究表明,治疗抑郁症可以改善心血管疾病的预后,抑郁症相关的生活方式的行为学因素(如缺乏治疗的依从性和不健康的生活方式)在老年人中更明显。影响抑郁症和心血管疾病之间错综复杂的遗传学因素,需要进一步研究。抑郁症的病理生理改变包括血小板活化、炎症标志物的表达、血管内皮功能障碍,可能是缓解抑郁症导致心血管疾病减少的机制。炎症可能是心血管疾病和抑郁症的共同发病机制之一。抑郁症患者的炎症标志物明显升高,炎症也会破坏动脉壁的功能。抑郁症也增加患者发生动脉炎症的可能性,并直接导致动脉粥样硬化及其并发症。然而,抑郁症加重炎症反应的内在机制仍不完全清楚。抑郁症患者常常有内分泌紊乱,如HPA 轴亢进和亚临床甲状腺功能减退,这会增加心血管疾病的发生风险。抑郁症相关的激素失调可能会导致HRV 降低和节律紊乱,可能增加心血管疾病的风险。血小板活化对动脉壁的修复有重要的作用,抑郁症患者血小板的活化和聚集,进一步引起动脉粥样硬化,其内在的机制仍有待确定。

目前,抑郁症在临床工作中仍未受到广大医生的重视,抑郁对躯体疾病的发生和发展有着广泛的不利影响。越来越多的证据表明,有效干预和治疗抑郁症可以改善老年患者的生活质量。

参考文献

[1]Kessler RC,Berglund P,DemLer O,et al.Lifetime prevalence and age-ofonset distributions of DSM - IV disorders in the National Comorbidity Survey Replication[J].Arch Gen Psychiatry,2005,62(6):593-602.

[2]Berry JD,Dyer A,Cai X,et al.Lifetime risks of cardiovascular disease[J].N Engl J Med,2012,366(4):321-329.

[3]Khan FM,Kulaksizoglu B,Cilingiroglu M.Depression and coronary heart disease[J].Curr Atheroscler Rep,2010,12(2):105-109.

[4]Anda R,Williamson D,Jones D,et al.Depressed affect,hopelessness,and the risk of ischemic heart disease in a cohort of U.S.adults[J].Epidemiology,1993,4(4):285-294.

[5]Holahan CJ,Pahl SA,Cronkite RC,et al.Depression and vulnerability to incident physical illness across 10 years[J].J Affect Disord,2010,123(1/3):222-229.

[6]Ford DE,Mead LA,Chang PP,et al.Depression is a risk factor for coronary artery disease in men:the precursors study[J].Arch Intern Med,1998,158(13):1422-1426.

[7]Surtees PG,Wainwright NW,Luben RN,et al.Depression and ischemic heart disease mortality:evidence from the EPIC-Norfolk United Kingdom prospective cohort study[J].Am J Psychiatry,2008,165(4):515-523.

[8]Meijer A,Conradi HJ,Bos EH,et al.Prognostic association of depression following myocardial infarction with mortality and cardiovascular events:a metaanalysis of 25 years of research[J].Gen Hosp Psychiatry,2011,33(3):203-216.

[9]Nabi H,Kivim ki M,Empana JP,et al.Combined effects of depressive symptoms and resting heart rate on mortality:the Whitehall II prospective cohort study[J].J Clin Psychiatry,2011,72(9):1199-1206.

[10]Hoen PW,Whooley MA,Martens EJ,et al.Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease[J].J Am Coll Cardiol,2010,56(11):838-844.

[11]Otte C,McCaffery J,Ali S,et al.Association of a serotonin transporter polymorphism(5-HTTLPR)with depression,perceived stress,and norepinephrine in patients with coronary disease:the Heart and Soul Study[J].Am J Psychiatry,2007,164(9):1379-1384.

[12]Su S,Lampert R,Lee F,et al.Common genes contribute to depressive symptoms and heart rate variability:the Twins Heart Study[J].Twin Res Hum Genet,2010,13(1):1-9.

[13]Bozzini S,Gambelli P,Boiocchi C,et al.Coronary artery disease and depression:possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms[J].Int J Mol Med,2009,24(6):813-818.

[14]Cohen BE,Panguluri P,Na B,et al.Psychological risk factors and the metabolic syndrome in patients with coronary heart disease:findings from the Heart and Soul Study[J].Psychiatry Res,2010,175(1/2):133-137.(https://www.daowen.com)

[15]Baune BT,Stuart M,Gilmour A,et al.Moderators of the relationship between depression and cardiovascular disorders:a systematic review[J].Gen Hosp Psychiatry,2012,34(5):478-492.

[16]Jokinen J,Nordstrm P.HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients[J].J Affect Disord,2009,116(1/2):88-92.

[17]Vogelzangs N,Beekman AT,Milaneschi Y,et al.Urinary cortisol and sixyear risk of all-cause and cardiovascular mortality[J].J Clin Endocrinol Metab,2010,95(11):4959-4964.

[18]Almeida OP,Alfonso H,Flicker L,et al.Thyroid hormones and depression:the Health in Men study[J].Am J Geriatr Psychiatry,2011,19(9):763-770.

[19]Howren MB,Lamkin DM,Suls J.Associations of depression with Creactive protein,IL-1,and IL-6:a meta-analysis[J].Psychosom Med,2009,71(2):171-186.

[20]Elovainio M,Aalto AM,Kivimki M,et al.Depression and C-reactive protein:population-based Health 2000 Study[J].Psychosom Med,2009,71(4):423-430.

[21]Pasco JA,Nicholson GC,Williams LJ,et al.Association of high -sensitivity C-reactive protein with de novo major depression[J].Br J Psychiatry,2010,197(5):372-377.

[22]Davidson KW,Schwartz JE,Kirkland SA,et al.Relation of inflammation to depression and incident coronary heart disease(from the Canadian Nova Scotia Health Survey[NSHS95]Prospective Population Study)[J].Am J Cardiol,2009,103(6):755-761.

[23]Blasco-Lafarga C,Martinez-Navarro I,Sisamon ME,et al.Linear and nonlinear heart rate dynamics in elderly inpatients.Relations with comorbidity and depression[J].Medicina(Kaunas),2010,46(6):393-400.

[24]Parakh K,Sakhuja A,Bhat U,et al.Platelet function in patients with depression[J].South Med J,2008,101(6):612-617.

[25]Gehi A,Musselman D,Otte C,et al.Depression and platelet activation in outpatients with stable coronary heart disease:findings from the Heart and Soul Study[J].Psychiatry Res,2010,175(3):200-204.

[26]Atar D,Malinin A,Takserman A,et al.Escitalopram,but not its major metabolites,exhibits antiplatelet activity in humans[J].J Clin Psychopharmacol,2006,26(2):172-177.

[27]Tomfohr LM,Martin TM,Miller GE.Symptoms of depression andimpaired endothelial function in healthy adolescent women[J].J Behav Med,2008,31(2):137-143.

[28]Cooper DC,Tomfohr LM,Milic MS,et al.Depressed mood and flowmediated dilation:a systematic review and meta-analysis[J].Psychosom Med,2011,73(5):360-369.

[29]Yager S,Forlenza MJ,Miller GE.Depression and oxidative damage to lipids[J].Psychoneuroendocrinology,2010,35(9):1356-1362.

[30]Maes M,Mihaylova I,Kubera M,et al.Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression:markers that further explain the higher incidence of neurodegeneration and coronary artery disease[J].J Affect Disord,2010,125(1/3):287-294.

(王昊飞 贺丹军)

✍AI写作